# Systemic Necrotizing Medium-Vessel Vasculitis Clinically Consistent With Polyarteritis Nodosa: A Detailed Case Report

**Authors:** Niyas Khalid Ottu Para, Seema Rab, Asiya Pathan, Eman F Sharaf

PMC · DOI: 10.7759/cureus.102178 · Cureus · 2026-01-23

## TL;DR

This case report describes a rare vasculitis condition in a 33-year-old man, highlighting the challenges in diagnosis and the importance of clinical judgment.

## Contribution

The paper presents a detailed case of polyarteritis nodosa with a focus on diagnostic challenges and clinical decision-making.

## Key findings

- The patient showed multisystem involvement and responded well to corticosteroid therapy.
- Superficial biopsy and imaging had low diagnostic yield, emphasizing clinical features for diagnosis.
- The case underscores the limitations of current diagnostic methods in early PAN.

## Abstract

Polyarteritis nodosa (PAN) is a rare necrotizing vasculitis of medium-sized arteries presenting with heterogeneous multisystem involvement. Diagnosis is challenging due to the absence of specific biomarkers, frequent anti-neutrophil cytoplasmic antibodies (ANCA) negativity, variable early imaging findings, and low diagnostic yield of superficial biopsies. We report the case of a 33-year-old man experiencing a four-month evolution of recurrent inflammatory episodes involving abdominal, neurological, cutaneous, and cardiopulmonary systems. He developed dusky necrotizing vasculitic lesions, mononeuritis multiplex-type neuropathy, constitutional symptoms, markedly elevated inflammatory markers, and demonstrated a dramatic response to corticosteroid therapy. Computed tomography angiography was normal, and a superficial punch biopsy performed after steroid initiation was nondiagnostic, reflecting known limitations of sampling depth and timing. Despite this, clinical features, disease trajectory, exclusion of alternative vasculitides, and classical steroid responsiveness strongly supported systemic PAN. This case highlights the diagnostic limitations of biopsy and imaging in early PAN and emphasizes the need for clinical judgment and timely treatment.

## Linked entities

- **Diseases:** Polyarteritis nodosa (MONDO:0019170), vasculitis (MONDO:0018882)

## Full-text entities

- **Genes:** CMPK1 (cytidine/uridine monophosphate kinase 1) [NCBI Gene 51727] {aka CK, CMK, CMPK, UMK, UMP-CMPK, UMPK}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, C3 (complement C3) [NCBI Gene 718] {aka AHUS5, ARMD9, ASP, C3a, C3b, CPAMD1}, MPO (myeloperoxidase) [NCBI Gene 4353], PRTN3 (proteinase 3) [NCBI Gene 5657] {aka ACPA, AGP7, C-ANCA, CANCA, MBN, MBT}
- **Diseases:** pulmonary hemorrhage (MESH:D006470), inflammatory infiltrates (MESH:D017254), neuropathic burning pain (MESH:D009437), reactive thrombocytosis (MESH:D013922), arrhythmia (MESH:D001145), necrotic vasculitic lesions (MESH:D009059), ischemic organ injury (MESH:D009102), organ damage (MESH:D000092124), cellulitis (MESH:D002481), bacterial (MESH:D001424), rashes (MESH:D005076), hypersensitivity (MESH:D004342), acalculus cholecystitis (MESH:D002764), pneumonia (MESH:D011014), systemic vasculitis (MESH:D056647), hemoptysis (MESH:D006469), myalgias (MESH:D063806), epistaxis (MESH:D004844), CHCC (MESH:C535395), fatigue (MESH:D005221), chest pain (MESH:D002637), necrosis (MESH:D009336), pulmonary embolism (MESH:D011655), erythema (MESH:D004890), urinary abnormalities (MESH:C536480), fever (MESH:D005334), fibrinoid necrosis (MESH:D038261), small-vessel vasculitides (MESH:D059345), ischemia (MESH:D007511), stenoses (MESH:D003251), HIV (MESH:D015658), Immune-complex (MESH:D007105), PAN (MESH:D010488), neuropathy (MESH:D009422), thrombus (MESH:D013927), inflammation (MESH:D007249), glomerulonephritis (MESH:D005921), -vessel vasculitis (MESH:D014657), EGPA (MESH:D014890), eosinophilic granulomatosis with polyangitis (MESH:D017681), necrotic skin lesions (MESH:D012871), sinusitis (MESH:D012852), MPA (MESH:D055953), acute coronary syndrome (MESH:D054058), nerve damage (MESH:D000080902), pain (MESH:D010146), granulomatosis with polyangitis (MESH:D015267), neuropathic symptoms (MESH:D001750), microscopic polyangitis (MESH:D046728), sensory deficits (MESH:D012678), ischemic injury (MESH:D017202), mono- or polyneuropathy (MESH:D011115), ANCA (MESH:D056648), arterial damage (MESH:D014652), pulmonary capillaritis (MESH:D008171), ischemic (MESH:D002545), aneurysms (MESH:D000783), microcytosis (OMIM:616959), infection (MESH:D007239), livedo (MESH:D000090122)
- **Chemicals:** steroid (MESH:D013256), lipid (MESH:D008055), Gabapentin (MESH:D000077206), prednisolone (MESH:D011239), dexamethasone (MESH:D003907)
- **Species:** Hepatitis B virus (no rank) [taxon 10407], hepatitis C virus [taxon 11103], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12925990/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12925990/full.md

## References

11 references — full list in the complete paper: https://tomesphere.com/paper/PMC12925990/full.md

---
Source: https://tomesphere.com/paper/PMC12925990